Research Focus:
Dr. Reitz has had >36 years of demonstrated accomplishment as a medicinal chemist in the pharmaceutical industry, including nearly 26 years with Johnson & Johnson. For 16 years at the Spring House, Pennsylvania facility of Johnson & Johnson he led the medicinal chemistry research effort in the area of the diseases of the central nervous system for both psychiatry and neurology. He is co-inventor as well as Team Leader, in most cases, for eight compounds that have entered human clinical trials, including mazapertine and trigriluzole, currently in Phase II clinical trials. He has >140 scientific publications and 61 issued U.S. patents, and is the Editor-in-Chief of the journal Current Topics in Medicinal Chemistry. He has extensive experience in project and portfolio management, target validation, hit triage, hit to lead and lead optimization medicinal chemistry, eADME profiling, and preclinical candidate selection. He is also Adjunct Professor at Drexel University College of Medicine, holds an Executive Masters in Technology Management from the University of Pennsylvania (Wharton, Penn Engineering), and is a Moore Fellow in the Management of Technology (U. Penn.).

years treating ALS: 36

Number of ALS Patients Treated Annually:

Details & contact info

ALS Biopharma

3805 Old Easton Road
Doylestown, PA, United States, 18902

Phone: (215) 589-6416

View Website

Send a message to